NCT01755429View on ClinicalTrials.gov

To Characterize the Safety and Tolerability of Eculizumab in Two Japanese aHUS Patients

CompletedOBSERVATIONAL
Enrollment

2

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

May 31, 2012

Study Completion Date

July 31, 2012

Conditions
ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS)
Trial Locations (2)

Unknown

Shinshu University School of Medicine, Matsumoto

Tokyo Medical and Dental University, Tokyo

Sponsors
All Listed Sponsors
lead

Alexion Pharmaceuticals, Inc.

INDUSTRY